FDA Rheumatology Drug Approvals: Pediatric lupus, spondyloarthritis and more

Slideshow

From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics.

From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics. 

Recent Videos
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Related Content
Physical Activity Linked to Reducing Depression Symptoms, Mediated by Pain

Physical Activity Linked to Reducing Depression Symptoms, Mediated by Pain

Chelsie Derman
July 25th 2024
Article
Emerging Agents in the Treatment of Rheumatic Diseases

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;Philip J. Mease, MD
October 2nd 2023
Podcast
HCPLive FDA Novel Drug Approvals Recap First Half 2024 thumbnail.

FDA News Recap: Novel Drug Approvals in First Half of 2024

Patrick Campbell
July 1st 2024
Article
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;John B. Boone, MD, FACR;Madelaine Feldman MD, FACR
August 31st 2023
Podcast
Vilde Øverlien Dåstøl, MD | Credit: Oslo University Hospital

Total Fish Intake in Pregnancy Could Alter Risk of Juvenile Arthritis in Offspring

Patrick Campbell
June 20th 2024
Article
Doctor and patient speaking to each other. | Credit: Fotolia

FIRST Questionnaire Can Help Detect Fibromyalgia in RA Patients

Patrick Campbell
June 20th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.